Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACT II: Colchicine Therapy Following PCI in ACS Patients
NCT06543082Phase 4Recruiting
- Sponsor
- CHA University
- Start
- Aug 2024
- Primary completion
- Dec 2028
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in acute coronary syndrome (ACS), sponsored by CHA University. Started Aug 2024; status: recruiting.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT06543082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06543082.